newsfilter
← Latest News
GlobeNewswire·

Molecular Templates Provides Corporate Update and Outlines 2022 Milestones

Unique PD-L1-mediated immune changes and early signs of anti-tumor activity with MT-6402 Continued dose-finding with MT-5111 and MT-0169 Pipeline advancing with IND planned for CTLA-4 program in 2H22 MTEM to Present at Evercore ISI 4th Annual He